Leo Pharma (Germany)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Immunology and Microbiology 23.7×
• Neuroscience 4.3×
• Economics, Econometrics and Finance 3.5×
• Health Professions 3.5×
• Medicine 2.7×

By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Traumatic Brain Injury Research and Therapeutic Uses of Natural Elements.

1. 1 Psoriasis: Treatment and Pathogenesis Immunology 0 works
2. 2 Spondyloarthritis Studies and Treatments Rheumatology 0 works
3. 3 Traumatic Brain Injury Research Epidemiology 0 works
4. 4 Therapeutic Uses of Natural Elements Complementary and Manual Therapy 0 works
5. 5 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
6. 6 Hidradenitis Suppurativa and Treatments Dermatology 0 works
7. 7 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
8. 8 Dermatology and Skin Diseases Dermatology 0 works
9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
10. 10 Asthma and respiratory diseases Physiology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 49% lower than in 2013–2017.

• KfH Kuratorium für Dialyse und Nierentransplantation
• UL (Germany)
• Toray International Europe (Germany)
• Institut für Molekularbiologie und Analytik (Germany)